Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Review ArticleClinical Studies

Morphological and Molecular Profiles and Pathways in Bladder Neoplasms

ANTONIO LOPEZ-BELTRAN, LIANG CHENG, ROBERTA MAZZUCCHELLI, MARISTELLA BIANCONI, ANA BLANCA, MARINA SCARPELLI and RODOLFO MONTIRONI
Anticancer Research September 2008, 28 (5B) 2893-2900;
ANTONIO LOPEZ-BELTRAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LIANG CHENG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERTA MAZZUCCHELLI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARISTELLA BIANCONI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANA BLANCA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARINA SCARPELLI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RODOLFO MONTIRONI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: r.montironi@univpm.it
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

After several decades of use of the Wealth Health Organization (WHO) 1973 grading system for bladder neoplasms (1973 WHO), a new grading system was adopted in 2004 by the WHO (2004 WHO). Some leading experts in the field of urogenital pathology have expressed their concerns with the 2004 WHO categorization system, both with regard to the nomenclature and the grading categories used. Several molecular and genetic studies have provided another perspective on the classification of urothelial neoplasms. The two most important developments are the identification of a mutation in the fibroblast growth factor receptor 3 gene in more than 50% of urothelial carcinomas and the discovery of cDNA profiles characteristic of different subsets of bladder cancer. There is strong correlation between the molecular findings and the 2004 WHO classification and prognosis.

  • Bladder neoplasms
  • bladder neoplasm classification
  • molecular classification
  • profiling
  • review

Footnotes

  • Received April 3, 2008.
  • Revision received June 8, 2008.
  • Accepted June 16, 2008.
  • Copyright© 2008 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 28 (5B)
Anticancer Research
Vol. 28, Issue 5B
September-October 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Morphological and Molecular Profiles and Pathways in Bladder Neoplasms
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Morphological and Molecular Profiles and Pathways in Bladder Neoplasms
ANTONIO LOPEZ-BELTRAN, LIANG CHENG, ROBERTA MAZZUCCHELLI, MARISTELLA BIANCONI, ANA BLANCA, MARINA SCARPELLI, RODOLFO MONTIRONI
Anticancer Research Sep 2008, 28 (5B) 2893-2900;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Morphological and Molecular Profiles and Pathways in Bladder Neoplasms
ANTONIO LOPEZ-BELTRAN, LIANG CHENG, ROBERTA MAZZUCCHELLI, MARISTELLA BIANCONI, ANA BLANCA, MARINA SCARPELLI, RODOLFO MONTIRONI
Anticancer Research Sep 2008, 28 (5B) 2893-2900;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial
  • Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study
  • Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire